Tweets
Daily Recap: Day One + Two
https://t.co/USBFbTWzGG https://t.co/RV9RyLLNmX
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Abatacept: is there a role before RA hits?
Dr. David Liew discusses OP0130 at EULAR 2023 in Milan, Italy.
https://t.co/XJXabAULhn https://t.co/Hv93HKolKH
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Among 247.3 million US adults. 10.0% (20.3 million) had CVD & 56% were at risk for CVD. Yet only 3.6 million CVD (18%) & 34.5 million at risk for CVD (26%) used wearable devices (compared to 29% in US adults, but less than half wear every day. https://t.co/04xqtkw61x https://t.co/ETTjamvHi2
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Watch: Zoster Management and Vaccination
Drs. Janet Pope and Kevin Winthrop at EULAR 2023 in Milan, Italy.
https://t.co/eOhXzw3Epy https://t.co/h3NoDggg5x
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
ANCA-associated vasculitis: beyond therapy with rituximab?
AAV is a group of multi-system autoimmune small vessel vasculitides which includes GPA, MPA and EGPA.
https://t.co/z8RgNYvBiO https://t.co/NI4z4kSAHQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Methotrexate - an old trusted friend who deserves better
MTX has been used as the anchor drug for the treatment of RA and PsA for many years. It has been co-prescribed with biologics and JAKi in clinical trials and as well as in clinical practice.
https://t.co/rSHsysJQ46 https://t.co/OKfBiMlqyg
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Congratulations to Professor Daniel Aletaha - the New EULAR President. Daniel Aletaha is the Professor and Head of the Division of Rheumatology at the Medical University Vienna https://t.co/NgLM4rk7Xd https://t.co/Z9XisPQb2M
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Rheumatoid Arthritis, Radiomics and Interstitial Lung Disease
Drs. Antoni Chan and Vincenzo Venerito discuss abstracts OP0127 and POS0855 presented at EULAR 2023 in Milan, Italy.
https://t.co/SuMMrkwfvk https://t.co/hSSPKIW4Os
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
SLE Trial: Dual BTK JAK Blockade compared Upadacitinib Monotherapy
Dr. Yuz Yusof discusses abstract OP0139 presented at EULAR 2023 in Milan, Italy.
https://t.co/os1tyiDnuT https://t.co/G0owdGek7f
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Difficult to treat RA is Actually Difficult to Define
Dr. Janet Pope discusses abstract OP0134 presented at EULAR 2023 in Milan, Italy.
https://t.co/0J9mH9n8jJ https://t.co/JT1hGp2S5w
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
How to avoid POLYPHARMACY (taking too many medicines). JAMA overview on DE-prescribing. https://t.co/MNmBuuhsFF https://t.co/HQwcsYwj3N
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
CV and Cancer Risk with JAK inhibitors
Dr. Jonathan Kay discusses abstract OP0132 presented at EULAR 2023 in Milan, Italy.
https://t.co/SZLohnNEa1 https://t.co/ZEv0Q2NSBf
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
